Related Experiment Videos

Phospholamban gene dosage effects in chemically permeabilized mouse cardiac muscle

R T Wiedmann¹, B S Pan, E G Kranias

¹Department of Pharmacology, Merck Research Laboratories, West Point, Pennsylvania 19486, USA.

Annals of the New York Academy of Sciences

|December 22, 1999

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

[Comparison of quantitative smears prepared from EDTA-K2 anticoagulated bone marrow fluid and traditional bedside direct smears, and the clinical value of their combined use with peripheral blood smears].

Zhonghua yi xue za zhi·2026

AB-1002 gene therapy expressing active protein phosphatase inhibitor-1 in heart failure: Rationale and study design of the GenePHIT trial.

European journal of heart failure·2026

[Trends in fasting blood glucose among patients and health examinees in a tertiary hospital in Shanghai from 2005 to 2024].

Zhonghua yi xue za zhi·2025

[Performance validation and clinical application evaluation of fluorescent magnetic particle chemiluminescence method for the determination of sIgE].

Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine]·2025

[Differentiate between the reference interval and the clinical diagnosis and treatment decision threshold for alanine aminotransferase].

Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology·2022

Prevalence and cardiac phenotype of patients with a phospholamban mutation.

Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation·2018

See all related articles